MedTrace Logo

Observational Study Investigating Clinical & Anthropometric Characteristics of Children With Achondroplasia.

NCT03794609 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 315

Last updated 2024-10-17

Study results available
· View outcomes & findings →

Summary

This is a registry study in children with achondroplasia, age 0-10 years, to be conducted at multiple clinical centers in several countries. Information collected will include in anthropometric characteristics, related symptoms, tests, \& treatments

Children's information will be collected in the registry for a maximum of 5 years.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Pfizer Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
0 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-15
Primary Completion
2023-01-13
Completion
2023-01-13

Countries

  • United States
  • Australia
  • Belgium
  • Canada
  • China
  • Denmark
  • France
  • Germany
  • Italy
  • Japan
  • Portugal
  • Spain
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03794609 on ClinicalTrials.gov